UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

The Lancet (British edition), 2007-03, Vol.369 (9564), p.827-835

2007

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

BMC cardiovascular disorders, 2012-05, Vol.12 (1), p.33-33, Article 33

2012

Link zum Volltext

Verfügbarkeit prüfen

Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Trials, 2012-01, Vol.13 (1), p.1-1, Article 1

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

European heart journal, 2015-05, Vol.36 (20), p.1264-1272

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial registration: looking back and moving ahead

The Lancet (British edition), 2007-06, Vol.369 (9577), p.1909-1911

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trial Registration — Looking Back and Moving Ahead

The New England journal of medicine, 2007-06, Vol.356 (26), p.2734-2736

2007

Link zum Volltext

Verfügbarkeit prüfen

Can we pull the plug on warfarin in atrial fibrillation?

The Lancet (British edition), 2003-11, Vol.362 (9397), p.1686-1687

Verheugt, Freek WA

2003

Link zum Volltext

Verfügbarkeit prüfen

The Role of the Cardiologist in the Primary Prevention of Cardiovascular Disease With Aspirin

Journal of the American College of Cardiology, 2015-01, Vol.65 (2), p.122-124

Verheugt, Freek W.A., MD

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

The Lancet (British edition), 2004-08, Vol.364 (9435), p.675-684

2004

Link zum Volltext

Verfügbarkeit prüfen

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial

The American heart journal, 2015-10, Vol.170 (4), p.683-694.e3

2015

Link zum Volltext

Verfügbarkeit prüfen

Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease

Clinical therapeutics, 2014-09, Vol.36 (9), p.1176-1181

2014

Link zum Volltext

Verfügbarkeit prüfen

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2017-02, Vol.103 (4), p.293

2017

Link zum Volltext

Verfügbarkeit prüfen

Routine Angioplasty after Fibrinolysis — How Early Should “Early” Be?

The New England journal of medicine, 2009-06, Vol.360 (26), p.2779-2781

Verheugt, Freek W.A

2009

Link zum Volltext

Verfügbarkeit prüfen

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

The American heart journal, 2012-04, Vol.163 (4), p.531-534

Verheugt, Freek W.A., MD, FACC, FESC

2012

Link zum Volltext

Verfügbarkeit prüfen

Low Body Weight and Prescribing DOACs in Atrial Fibrillation

Journal of the American College of Cardiology, 2019-03, Vol.73 (8), p.932-934

Verheugt, Freek W.A.

2019

Link zum Volltext

Verfügbarkeit prüfen

Who is ineligible for warfarin in atrial fibrillation?

The Lancet (British edition), 2009-08, Vol.374 (9689), p.510-511

Verheugt, Freek WA

2009

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)

Journal of the American College of Cardiology, 2019-08, Vol.74 (5), p.699-711

2019

Link zum Volltext

Verfügbarkeit prüfen

Who is to blame?

The Lancet (British edition), 2002-09, Vol.360 (9335), p.789-789

Verheugt, Freek WA

2002

Link zum Volltext

Verfügbarkeit prüfen

Antiplatelet therapy and anticoagulants – Authors' reply

The Lancet (British edition), 2013-07, Vol.382 (9886), p.25-25

2013

Link zum Volltext

Verfügbarkeit prüfen

Good old warfarin for stroke prevention in atrial fibrillation

The Lancet (British edition), 2006-06, Vol.367 (9526), p.1877-1878

Verheugt, Freek WA

2006

Link zum Volltext

Verfügbarkeit prüfen

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

European heart journal. Acute cardiovascular care, 2019-12, Vol.8 (8), p.745-754

2019

Link zum Volltext

Verfügbarkeit prüfen

Timing of angiography after fibrinolysis for ST-elevation acute myocardial infarction

Current opinion in cardiology, 2010-07, Vol.25 (4), p.302-304

Verheugt, Freek WA

2010

Link zum Volltext

Verfügbarkeit prüfen

An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial

The American heart journal, 2021-04, Vol.234, p.42-50

2021

Link zum Volltext

Verfügbarkeit prüfen

Lyse now, stent later: the grace of GRACIA

The Lancet (British edition), 2004-09, Vol.364 (9439), p.1014-1015

Verheugt, Freek WA

2004

Link zum Volltext

Verfügbarkeit prüfen

Sympathoinhibitory effect of statins in chronic heart failure

Clinical autonomic research, 2010-04, Vol.20 (2), p.73-78

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Humans
(41)
Male
(21)
Cardiac & Cardiovascular Systems
(19)
Cardiovascular System & Cardiology
(19)
Female
(19)
General & Internal Medicine
(19)
Medicine, General & Internal
(19)
Cardiovascular Disease
(16)
Middle Aged
(16)
Heart Attacks
(15)
Aged
(12)
Cardiology
(12)
Aspirin
(11)
Platelet Aggregation Inhibitors - Therapeutic Use
(10)
Anticoagulants - Therapeutic Use
(9)
Drug Therapy
(9)
Risk Factors
(9)
Aspirin - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Clinical trial registration: looking back and moving ahead

Clinical Trial Registration — Looking Back and Moving Ahead

Can we pull the plug on warfarin in atrial fibrillation?

The Role of the Cardiologist in the Primary Prevention of Cardiovascular Disease With Aspirin

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Routine Angioplasty after Fibrinolysis — How Early Should “Early” Be?

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

Low Body Weight and Prescribing DOACs in Atrial Fibrillation

Who is ineligible for warfarin in atrial fibrillation?

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)

Who is to blame?

Antiplatelet therapy and anticoagulants – Authors' reply

Good old warfarin for stroke prevention in atrial fibrillation

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Timing of angiography after fibrinolysis for ST-elevation acute myocardial infarction

An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial

Lyse now, stent later: the grace of GRACIA

Sympathoinhibitory effect of statins in chronic heart failure

Aktive Filter

Suchergebnisse filtern